Video

Pharmacy Week in Review: July 15, 2016

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can’t miss for the busy pharmacy professional.

Featured article: FDA Approves First OTC Retinoid-Based Acne Treatment

Related Videos
Related Content
Inflammatory skin in Eczema, Atopic Dermatitis (AD) - top view 3d illustration
December 24th 2024

Dupilumab Lowers Incidence of Psychiatric and Sleep Disorders in Patients With Atopic Dermatitis

Luke Halpern, Assistant Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
GLP-1, Ozempic, Diabetes, Weight Loss, Wegovy | Image Credit: © zimmytws | stock.adobe.com
December 24th 2024

RECAP: 2024 Updates in the GLP-1 Space

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection
Published: December 23rd 2024 | Updated: December 23rd 2024

FDA Approves First Generic of Liraglutide Injection to Lower Blood Sugar in Patients With Type 2 Diabetes

Luke Halpern, Assistant Editor
Pharmacist holding nasal spray bottle | Image Credit: © I Viewfinder - stock.adobe.com
December 23rd 2024

EPINEPHrine Nasal Solution, USP Recalled for Lack of Approval, Misbranding

Alexandra Gerlach, Associate Editor